脑脊液中循环肿瘤DNA与弥漫性大B细胞淋巴瘤患者中枢神经系统高风险受累的相关性 - Suppr

Association of circulating tumor DNA from the cerebrospinal fluid with high-risk CNS involvement in patients with diffuse large B-cell lymphoma.

作者信息

Wang Xiaoxiao, Gao Yan, Shan Changguo, Lai Mingyao, He Haixia, Bai Bing, Ping Liqin, Rong Qixiang, Ai Ruyu, Wen Lei, Zhou Zhaoming, Yu Ruoying, Ou Qiuxiang, Wu Xue, Wang Xiaoxia, Shao Yang W, Cai Linbo, Huang Huiqiang

机构信息

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.

Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.

出版信息

Clin Transl Med. 2021 Jan;11(1):e236. doi: 10.1002/ctm2.236.

DOI:10.1002/ctm2.236

PMID:33463068

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7809600/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a1/7809600/2ad6de4a31b5/CTM2-11-e236-g001.jpg

相似文献

Association of circulating tumor DNA from the cerebrospinal fluid with high-risk CNS involvement in patients with diffuse large B-cell lymphoma.

Clin Transl Med. 2021 Jan;11(1):e236. doi: 10.1002/ctm2.236.

Orexin secretion abnormality involved in excessive somnolence in CNS lymphoma without hypothalamic lesions.

J Clin Neurosci. 2019 Jun;64:6-7. doi: 10.1016/j.jocn.2019.03.066. Epub 2019 Apr 5.

Diagnostic value of interleukin-10 in cerebrospinal fluid for diffuse large B-cell lymphoma of the central nervous system.

J Neurooncol. 2015 Jan;121(1):177-83. doi: 10.1007/s11060-014-1622-z. Epub 2014 Sep 26.

Tumor cell-free DNA detection in CSF for primary CNS lymphoma diagnosis.

Acta Neuropathol Commun. 2019 Mar 18;7(1):43. doi: 10.1186/s40478-019-0692-8.

[A case of secondary central nervous system lymphoma presenting marked hypoglycorrhachia].

Rinsho Shinkeigaku. 2019 Jun 22;59(6):365-370. doi: 10.5692/clinicalneurol.cn-001284. Epub 2019 May 29.

Characteristics of Central Nervous System (CNS) Involvement in Children With Non-Hodgkin's Lymphoma (NHL) and the Diagnostic Value of CSF Flow Cytometry in CNS Positive Disease.

Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211016372. doi: 10.1177/15330338211016372.

Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma.

J Neurovirol. 2002 Oct;8(5):432-8. doi: 10.1080/13550280260422730.

Circulating tumour DNA, microRNA and metabolites in cerebrospinal fluid as biomarkers for central nervous system malignancies.

J Clin Pathol. 2019 Apr;72(4):271-280. doi: 10.1136/jclinpath-2018-205414. Epub 2018 Nov 22.

Flower-like/clover leaf lymphocytes appear in various diseases: cerebrospinal fluid cytology case with review of the literature.

Diagn Cytopathol. 2015 Jan;43(1):88-90. doi: 10.1002/dc.23147. Epub 2014 Mar 8.

Cerebrospinal fluid circulating tumour DNA as a liquid biopsy for central nervous system malignancies.

Curr Opin Neurol. 2020 Dec;33(6):736-741. doi: 10.1097/WCO.0000000000000869.

引用本文的文献

Circulating tumor DNA - from biology to potential clinical applications in diffuse large B-cell lymphomas.

Contemp Oncol (Pozn). 2025;29(2):150-158. doi: 10.5114/wo.2025.150452. Epub 2025 May 9.

Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma.

Leukemia. 2024 Jul;38(7):1541-1552. doi: 10.1038/s41375-024-02279-7. Epub 2024 May 15.

Recent updates on central nervous system prophylaxis in patients with high-risk diffuse large B-cell lymphoma.

Exp Hematol Oncol. 2024 Jan 3;13(1):1. doi: 10.1186/s40164-023-00467-2.

Genomic alterations associated with pseudoprogression and hyperprogressive disease during anti-PD1 treatment for advanced non-small-cell lung cancer.

Front Oncol. 2023 Nov 9;13:1231094. doi: 10.3389/fonc.2023.1231094. eCollection 2023.

PD-1 blockade combined with ICE regimen in relapsed/refractory diffuse large B-cell lymphoma.

Ann Hematol. 2023 Aug;102(8):2189-2198. doi: 10.1007/s00277-023-05292-5. Epub 2023 Jun 12.

Liquid biopsy in lymphoma: Is it primed for clinical translation?

EJHaem. 2021 May 12;2(3):616-627. doi: 10.1002/jha2.212. eCollection 2021 Aug.

Advances in Multi-Omics Study of Prognostic Biomarkers of Diffuse Large B-Cell Lymphoma.

Int J Biol Sci. 2022 Jan 9;18(4):1313-1327. doi: 10.7150/ijbs.67892. eCollection 2022.

Clinical utility of cerebrospinal fluid-derived circular RNAs in lung adenocarcinoma patients with brain metastases.

J Transl Med. 2022 Feb 5;20(1):74. doi: 10.1186/s12967-022-03274-1.

Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma.

Cancer Res Treat. 2022 Apr;54(2):597-612. doi: 10.4143/crt.2021.752. Epub 2021 Jul 23.

Role of Circulating Tumor DNA in Hematological Malignancy.

Cancers (Basel). 2021 Apr 25;13(9):2078. doi: 10.3390/cancers13092078.

本文引用的文献

Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases.

Ann Oncol. 2019 Feb 1;30(2):211-218. doi: 10.1093/annonc/mdy544.

CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP.

J Clin Oncol. 2016 Sep 10;34(26):3150-6. doi: 10.1200/JCO.2015.65.6520. Epub 2016 Jul 5.

Prevention of CNS relapse in diffuse large B-cell lymphoma.

Lancet Oncol. 2011 Dec;12(13):1258-66. doi: 10.1016/S1470-2045(11)70140-1. Epub 2011 Sep 18.

Double-hit B-cell lymphomas.

Blood. 2011 Feb 24;117(8):2319-31. doi: 10.1182/blood-2010-09-297879. Epub 2010 Nov 30.

MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy.

Blood. 2009 Oct 22;114(17):3533-7. doi: 10.1182/blood-2009-05-220095. Epub 2009 Aug 24.

Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up.

Ann Oncol. 2007 Jun;18(6):1085-9. doi: 10.1093/annonc/mdm073. Epub 2007 Mar 15.

Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

Ann Oncol. 2007 Jan;18(1):149-157. doi: 10.1093/annonc/mdl327. Epub 2006 Oct 3.

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab.

Ann Oncol. 2004 Jan;15(1):129-33. doi: 10.1093/annonc/mdh013.

Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d'Etudes des Lymphomes de l'Adulte.

Ann Oncol. 2000 Jun;11(6):685-90. doi: 10.1023/a:1008394827806.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Association of circulating tumor DNA from the cerebrospinal fluid with high-risk CNS involvement in patients with diffuse large B-cell lymphoma.

作者信息

机构信息

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.

Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.

出版信息

Clin Transl Med. 2021 Jan;11(1):e236. doi: 10.1002/ctm2.236.

DOI:10.1002/ctm2.236

PMID:33463068

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7809600/

Abstract

摘要

相似文献

Association of circulating tumor DNA from the cerebrospinal fluid with high-risk CNS involvement in patients with diffuse large B-cell lymphoma.

Clin Transl Med. 2021 Jan;11(1):e236. doi: 10.1002/ctm2.236.

Orexin secretion abnormality involved in excessive somnolence in CNS lymphoma without hypothalamic lesions.

J Clin Neurosci. 2019 Jun;64:6-7. doi: 10.1016/j.jocn.2019.03.066. Epub 2019 Apr 5.

Diagnostic value of interleukin-10 in cerebrospinal fluid for diffuse large B-cell lymphoma of the central nervous system.

J Neurooncol. 2015 Jan;121(1):177-83. doi: 10.1007/s11060-014-1622-z. Epub 2014 Sep 26.

Tumor cell-free DNA detection in CSF for primary CNS lymphoma diagnosis.

Acta Neuropathol Commun. 2019 Mar 18;7(1):43. doi: 10.1186/s40478-019-0692-8.

[A case of secondary central nervous system lymphoma presenting marked hypoglycorrhachia].

Rinsho Shinkeigaku. 2019 Jun 22;59(6):365-370. doi: 10.5692/clinicalneurol.cn-001284. Epub 2019 May 29.

Characteristics of Central Nervous System (CNS) Involvement in Children With Non-Hodgkin's Lymphoma (NHL) and the Diagnostic Value of CSF Flow Cytometry in CNS Positive Disease.

Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211016372. doi: 10.1177/15330338211016372.

Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma.

J Neurovirol. 2002 Oct;8(5):432-8. doi: 10.1080/13550280260422730.

Circulating tumour DNA, microRNA and metabolites in cerebrospinal fluid as biomarkers for central nervous system malignancies.

J Clin Pathol. 2019 Apr;72(4):271-280. doi: 10.1136/jclinpath-2018-205414. Epub 2018 Nov 22.

Flower-like/clover leaf lymphocytes appear in various diseases: cerebrospinal fluid cytology case with review of the literature.

Diagn Cytopathol. 2015 Jan;43(1):88-90. doi: 10.1002/dc.23147. Epub 2014 Mar 8.

Cerebrospinal fluid circulating tumour DNA as a liquid biopsy for central nervous system malignancies.

Curr Opin Neurol. 2020 Dec;33(6):736-741. doi: 10.1097/WCO.0000000000000869.

引用本文的文献

Circulating tumor DNA - from biology to potential clinical applications in diffuse large B-cell lymphomas.

Contemp Oncol (Pozn). 2025;29(2):150-158. doi: 10.5114/wo.2025.150452. Epub 2025 May 9.

Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma.

Leukemia. 2024 Jul;38(7):1541-1552. doi: 10.1038/s41375-024-02279-7. Epub 2024 May 15.

Recent updates on central nervous system prophylaxis in patients with high-risk diffuse large B-cell lymphoma.

Exp Hematol Oncol. 2024 Jan 3;13(1):1. doi: 10.1186/s40164-023-00467-2.

Genomic alterations associated with pseudoprogression and hyperprogressive disease during anti-PD1 treatment for advanced non-small-cell lung cancer.

Front Oncol. 2023 Nov 9;13:1231094. doi: 10.3389/fonc.2023.1231094. eCollection 2023.

PD-1 blockade combined with ICE regimen in relapsed/refractory diffuse large B-cell lymphoma.

Ann Hematol. 2023 Aug;102(8):2189-2198. doi: 10.1007/s00277-023-05292-5. Epub 2023 Jun 12.

Liquid biopsy in lymphoma: Is it primed for clinical translation?

EJHaem. 2021 May 12;2(3):616-627. doi: 10.1002/jha2.212. eCollection 2021 Aug.

Advances in Multi-Omics Study of Prognostic Biomarkers of Diffuse Large B-Cell Lymphoma.

Int J Biol Sci. 2022 Jan 9;18(4):1313-1327. doi: 10.7150/ijbs.67892. eCollection 2022.

Clinical utility of cerebrospinal fluid-derived circular RNAs in lung adenocarcinoma patients with brain metastases.

J Transl Med. 2022 Feb 5;20(1):74. doi: 10.1186/s12967-022-03274-1.

Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma.

Cancer Res Treat. 2022 Apr;54(2):597-612. doi: 10.4143/crt.2021.752. Epub 2021 Jul 23.

Role of Circulating Tumor DNA in Hematological Malignancy.

Cancers (Basel). 2021 Apr 25;13(9):2078. doi: 10.3390/cancers13092078.

本文引用的文献

Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases.

Ann Oncol. 2019 Feb 1;30(2):211-218. doi: 10.1093/annonc/mdy544.

CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP.

J Clin Oncol. 2016 Sep 10;34(26):3150-6. doi: 10.1200/JCO.2015.65.6520. Epub 2016 Jul 5.

Prevention of CNS relapse in diffuse large B-cell lymphoma.

Lancet Oncol. 2011 Dec;12(13):1258-66. doi: 10.1016/S1470-2045(11)70140-1. Epub 2011 Sep 18.

Double-hit B-cell lymphomas.

Blood. 2011 Feb 24;117(8):2319-31. doi: 10.1182/blood-2010-09-297879. Epub 2010 Nov 30.

MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy.

Blood. 2009 Oct 22;114(17):3533-7. doi: 10.1182/blood-2009-05-220095. Epub 2009 Aug 24.

Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up.

Ann Oncol. 2007 Jun;18(6):1085-9. doi: 10.1093/annonc/mdm073. Epub 2007 Mar 15.

Ann Oncol. 2007 Jan;18(1):149-157. doi: 10.1093/annonc/mdl327. Epub 2006 Oct 3.

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab.

Ann Oncol. 2004 Jan;15(1):129-33. doi: 10.1093/annonc/mdh013.

Ann Oncol. 2000 Jun;11(6):685-90. doi: 10.1023/a:1008394827806.

Association of circulating tumor DNA from the cerebrospinal fluid with high-risk CNS involvement in patients with diffuse large B-cell lymphoma.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Association of circulating tumor DNA from the cerebrospinal fluid with high-risk CNS involvement in patients with diffuse large B-cell lymphoma.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献